Ashish Agarwal retweetledi

CAR-T/BCMA therapy drastically enhanced the survival of relapsed/refractory multiple myeloma patients. However, high relapse rates and short remission times call for a more profound exploration. scRNAseq can offer valuable mechanistic insights.
Learn how👇
hubs.ly/Q02hyXbz0
English









